DrugPatentWatch Database Preview
Drugs in Development Information for Hexane-1,6-Diol
» See Plans and Pricing
What is the drug development status for Hexane-1,6-Diol?
Hexane-1,6-Diol is an investigational drug.
There have been 3 clinical trials for Hexane-1,6-Diol.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2012.
The most common disease conditions in clinical trials are Gastritis, Vitamin B 12 Deficiency, and Hypercholesterolemia. The leading clinical trial sponsors are Hospital Ángeles, Clínica Londres, Mexico City, Hospital Ángeles Metropolitano, Mexico City, and Centro Médico ABC Observatorio, Mexico City.
Summary for Hexane-1,6-Diol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 6,895 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 233 |
| Clinical Trial Progress | Phase 3 (2012-06-01) |
| Vendors | 57 |
Recent Clinical Trials for Hexane-1,6-Diol
| Title | Sponsor | Phase |
|---|---|---|
| Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico. | Centro InmunoQ, Mexico City | Phase 3 |
| Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico. | Centro Médico ABC Observatorio, Mexico City | Phase 3 |
| Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico. | Hospital Ángeles Metropolitano, Mexico City | Phase 3 |
Clinical Trial Summary for Hexane-1,6-Diol
Top disease conditions for Hexane-1,6-Diol
Top clinical trial sponsors for Hexane-1,6-Diol
US Patents for Hexane-1,6-Diol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
